Endoscopic Resection for Barrett's High-Grade Dysplasia and Early Esophageal Adenocarcinoma: An Essential Staging Procedure With Long-Term Therapeutic Benefit

被引:147
作者
Moss, Alan [1 ]
Bourke, Michael J. [1 ]
Hourigan, Luke F. [2 ]
Gupta, Saurabh [2 ]
Williams, Stephen J. [1 ]
Tran, Kayla [3 ]
Swan, Michael P. [1 ]
Hopper, Andrew D. [1 ]
Kwan, Vu [1 ]
Bailey, Adam A. [1 ]
机构
[1] Westmead Hosp, Dept Gastroenterol & Hepatol, Sydney, NSW, Australia
[2] Princess Alexandra Hosp, Dept Gastroenterol, Brisbane, Qld 4102, Australia
[3] Westmead Hosp, Dept Anat Pathol, Sydney, NSW, Australia
关键词
ARGON PLASMA COAGULATION; MUCOSAL RESECTION; INTRAEPITHELIAL NEOPLASIA; INTRAMUCOSAL CARCINOMA; COMPUTED-TOMOGRAPHY; CIRCUMFERENTIAL EMR; OPERATIVE MORTALITY; COMPLETE REMOVAL; HOSPITAL VOLUME; EARLY CANCER;
D O I
10.1038/ajg.2010.1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Patients with Barrett's high-grade dysplasia (HGD) or early esophageal adenocarcinoma (EAC) that is shown on biopsy alone continue to undergo esophagectomy without more definitive histological staging. Endoscopic resection (ER) may provide more accurate histological grading and local tumor (T) staging, definitive therapy, and complete Barrett's excision (CBE); however, long-term outcome data are limited. Our objective was to demonstrate the effect on histological grade or local T stage, efficacy, safety and long-term outcome of ER for Barrett's HGD/EAC and of CBE in suitable patients. METHODS: This prospective study at two Australian academic hospitals involved 75 consecutive patients over 7 years undergoing ER for biopsy-proven HGD or EAC, using multiband mucosectomy or cap technique. In addition, CBE by 2 -3-stage radical mucosectomy was attempted for all Barrett's segments <= 3 cm in length in patients aged <75 years with minimal comorbidities. RESULTS: Biopsy histology showed HGD in 89% of patients and EAC in 11%. However, ER histology resulted in altered grading or staging in 48% of patients (down 28%, up 20%), with HGD in 53%, low-grade dysplasia (LGD) in 19%, mucosal adenocarcinoma in 13%, submucosal adenocarcinoma in 9%, and no dysplasia in 4% of patients. The CBE success rate was 94%. Complications were one aspiration (hospitalization with full recovery) and six strictures successfully dilated endoscopically. During the mean follow-up of 31 months (range 3-89), there was no recurrence at ER sites, 11% developed metachronous lesions and five patients underwent esophagectomy for ER-demonstrated submucosal invasion. Esophagectomy specimens were T0N0M0 in three and T1N0M0 in two patients. There were no deaths due to adenocarcinoma. CONCLUSIONS: ER alters histological grade or local T stage in 48% of patients and dramatically reduces esophagectomy rates by providing safe and effective therapy. ER has a high success rate (94%) for CBE in short segment Barrett's esophagus.
引用
收藏
页码:1276 / 1283
页数:8
相关论文
共 45 条
[1]   Should patients with Barrett's oesophagus be kept under surveillance? The case for [J].
Armstrong, David .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2008, 22 (04) :721-739
[2]   Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus [J].
Behrens, A ;
May, A ;
Gossner, L ;
Günter, E ;
Pech, O ;
Vieth, M ;
Stolte, M ;
Seitz, G ;
Ell, C .
ENDOSCOPY, 2005, 37 (10) :999-1005
[3]   Surgeon volume and operative mortality in the United States [J].
Birkmeyer, JD ;
Stukel, TA ;
Siewers, AE ;
Goodney, PP ;
Wennberg, DE ;
Lucas, FL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2117-2127
[4]   Hospital volume and surgical mortality in the United States. [J].
Birkmeyer, JD ;
Siewers, AE ;
Finlayson, EVA ;
Stukel, TA ;
Lucas, FL ;
Batista, I ;
Welch, HG ;
Wennberg, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1128-1137
[5]   Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features [J].
Buskens, CJ ;
Westerterp, M ;
Lagarde, SM ;
Bergman, JJGHM ;
ten Kate, FJW ;
van Lanschot, JJB .
GASTROINTESTINAL ENDOSCOPY, 2004, 60 (05) :703-710
[6]   Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: An Italian experience [J].
Conio, Massimo ;
Repici, Alessandro ;
Cestari, Renzo ;
Blanchi, Sabrina ;
Lapertosa, Gabriella ;
Missale, Guido ;
Della Casa, Domenico ;
Villanacci, Vincenzo ;
Calandri, Pier Gigi ;
Filiberti, Rosangela .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (42) :6650-6655
[7]   Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus [J].
Dulai, GS ;
Jensen, DM ;
Cortina, G ;
Fontana, L ;
Ippoliti, A .
GASTROINTESTINAL ENDOSCOPY, 2005, 61 (02) :232-240
[8]   Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques [J].
Dumot, J. A. ;
Greenwald, B. D. .
ENDOSCOPY, 2008, 40 (12) :1026-1032
[9]   An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients [J].
Dumot, John A. ;
Vargo, John J., II ;
Fatk, Gary W. ;
Frey, Lorraine ;
Lopez, Rocio ;
Rice, Thomas W. .
GASTROINTESTINAL ENDOSCOPY, 2009, 70 (04) :635-644
[10]  
Edwards MJ, 1996, ANN SURG, V223, P585, DOI 10.1097/00000658-199605000-00014